US health regulator authorises Pfizer’s COVID pill as Omicron surges

Paxlovid, which comprises two types of tablet, was granted an emergency use authorisation by the FDA after a clinical trial showed it to reduce the risk of hospitalisations and deaths among at-risk people by 88%.

Read the full story: Read More